TIMIOS
Showing 1 - 3 of 3
Ocrelizumab and Ofatumumab Administration in Relapsing Multiple
Completed
- Relapsing Forms of Multiple Sclerosis
-
Lutherville, Maryland
- +1 more
Oct 19, 2022